All posts by imreal

Lateral Patient Transfer Technology Available on the Ocean Tomo Bid-Ask™ Market Addresses Growing State Requirements for Safe Patient Handling

Safe patient handling legislation has been passed in eleven states, including California, Illinois, New York, New Jersey, and Texas. The technology in Ocean Tomo Bid-Ask lot 140 benefits healthcare workers and the companies that employ them.

The Centers for Disease Control and Prevention (CDC), reports on patient handling hazard statistics outlined by the National Institute for Occupational Safety and Health (NIOSH) based on data compiled by the Bureau of Labor Statistics (BLS). BLS data from 2014 indicates the rate of injuries caused by overexertion across all industries was 33 per 10,000 full-time workers. The rate for nursing home workers is three times the national average and the rate for hospital workers two times the national average. NIOSH indicates the greatest risk factor for overexertion among healthcare workers is manual patient lifting, moving, and repositioning. Ocean Tomo Transactions, LLC will auction a portfolio of four U.S. patents and three U.S. trademarks for safe patient handling, a no-lift-required lateral patient transfer system. The portfolio covers a motorized lateral transfer device (Magic Mover™) and a transfer/repositioning sheet (Magic Sheet™). The entire portfolio is available through the Ocean Tomo Bid-Ask™ Market, auction lot 140. This innovative technology enables efficient patient transfer while helping to avoid injury and discomfort to caregivers and patients.

Safe patient handling legislation has been passed in eleven states, including California, Illinois, New York, New Jersey, and Texas. This invention benefits healthcare workers and the companies that employ them. The Innovation Group Board of Managers reinforces this technology’s importance and economic value, sharing “caregiver injuries due to lifting patients is rampant. We want to help caregivers and institutions transfer patients without lifting, helping mitigate Worker’s Compensation claims.”

View a video demonstration of the technology on the Ocean Tomo Bid-Ask market. To request bidder credentials or further information on this auction or other portfolios on the Ocean Tomo Bid-Ask™ Market, contact Olivia Becker at or +1 747 277 9337.

About Ocean Tomo Bid-Ask™ Market

The Ocean Tomo Bid-Ask Market is an open online platform to buy and sell patents. This market is an important step forward, both as a simplified solution for patent transactions as well as a source of information on patent pricing. The Ocean Tomo Bid-Ask Market uniquely combines the efficiency of an online platform with an experienced team of brokers fluent in both English and Mandarin. The market uses standard transaction documents and is open, transparent, and free to view.

Share article on social media or email:

Catalent Launches New OptiDose® Design Solution to Help Create Differentiated Treatments that are Successful for Innovators, Patients and Health Care Professionals

The OptiDose Design platform looks to evaluate all these considerations and provide options for final dose form decisions with an optimal combination of patient acceptance and adherence, differentiation versus any standard of care, manufacturability and cost

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the launch of its new OptiDose® Design Solution, at the Controlled Release Society (CRS) annual meeting, which is taking place virtually from July 25 – 29, 2021.

Catalent’s OptiDose Design Solution, led by Catalent’s scientific advisors, uses a design approach that combines data-driven scientific tools with Catalent’s extensive development expertise. Integrating pharmaceutics, and dose form design target patient characteristics, OptiDose Design Solution will help craft the ideal dose form for all stakeholders and optimize the potential of a molecule.

“Taking patient needs and market realities into consideration earlier in the drug development process, along with critical CMC and DMPK parameters, is vital for creating a successful treatment for patients, innovators and health care professionals alike,” commented Julien Meissonnier, Chief Scientific Officer at Catalent. He continued, “The OptiDose Design platform looks to evaluate all these considerations and provide options for final dose form decisions with an optimal combination of patient acceptance and adherence, differentiation versus any standard of care, manufacturability and cost.”

At the CRS meeting, Lisa Caralli, Director of Science and Technology at Catalent, will discuss the methodology of the OptiDose Design Solution, including how key product and patient factors are evaluated. Ms. Caralli’s presentation, titled “Strategies to Optimize the Dose Design Process to Create Better Treatments”, will use case studies to demonstrate how the correct guidance, at the optimum time, can help drug developers create better treatments.

Ms. Caralli has over 27 years of industry experience, and in her role at Catalent, works with pharmaceutical companies to identify appropriate development pathways for early development drug candidates. She has previously held roles at Ionis Pharmaceuticals and Amylin Pharmaceuticals and began her career at the Immune Response Corporation. Ms. Caralli holds a bachelor’s degree in biochemistry from the University of California at Davis, California.

OptiDose Design Solution is available throughout Catalent’s global oral dose network. For more information, please visit

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs approximately 15,000 people, including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Summit BHC Expands Presence in Colorado With the Opening of Johnstown Heights Behavioral Health

Summit BHC (“Summit”), a leading national provider of behavioral health and addiction treatment services, has opened Johnstown Heights Behavioral Health in Johnstown, CO.

Johnstown Heights Behavioral Health provides a full range of treatment services, including mental health crisis intervention, inpatient treatment, medication management, and intensive therapy for mental health issues. Johnstown Heights will also treat substance use disorder through a full continuum of care, including medically managed detox and intensive inpatient services. The facility has 92 beds that will serve adults, children and adolescents.

“The addition of Johnstown Heights Behavioral Health allows Summit to continue providing quality, affordable mental health and substance use disorder treatment to the residents of Colorado,” says Brent Turner, CEO of Summit. “This is an exciting expansion for us as we grow our services and reach more people in need of quality behavioral health services.”

Summit has 24 inpatient facilities nationally. This is its second in Colorado, in addition to Peak View Behavioral Health in Colorado Springs.

About Summit

Headquartered in Franklin, Tennessee and founded in 2013, Summit was established to develop and operate a leading network of behavioral health hospitals and addiction treatment centers throughout the country. The company’s primary focus is on psychiatric services and substance use disorder treatment within a flexible and dynamic continuum of care. The leadership team at Summit is composed of senior executives with decades of combined experience in the behavioral healthcare industry at the national level. The company currently owns and operates 24 freestanding facilities nationwide.

Share article on social media or email:

DayBreak’s Innovation to Reduce Emergency Services Usage is Honored with John A. Hartford Foundation Award from n4a

The Rapid Response Case Management (Rapid Response) program of DayBreak Adult Care Centers (DayBreak) received honorable mention for a Business Innovation Award for helping to create an age-friendly community in Alameda County.

In the first year of the program, Rapid Response improved healthcare and social support services for 70 clients, which reduced their frequent use of 911, EMS and emergency rooms, resulting in an estimated $2 million savings in hospital costs.

The innovative model demonstrates the catalyzing role that community-based organizations like DayBreak can take to drive meaningful change.

Business Innovation Award, Honorable Mention:

The National Association of Area Agencies on Aging’s (n4a) Aging and Disability Business Institute presented DayBreak with The John A. Hartford Foundation 2021 Business Innovation Award Honorable Mention for its Rapid Response Case Management program. The award was presented at n4a’s 46th Annual Conference and Tradeshow on July 21, 2021.

“Rapid Response is a model for how local agencies, community organizations and nonprofits can work together to improve lives,” said Ofra Paz, Executive Director of DayBreak. “We are honored to be recognized by n4a’s Aging and Disability Business Institute and The John A. Hartford Foundation. They share our commitment to better care for older adults that lowers overall costs.”

“We applaud the nominee organizations, all of whom are indispensable to their communities and have shown great ingenuity resilience and resourcefulness,” said Terry Fulmer, PhD, RN, FAAN, President of The John A. Hartford Foundation. “This award hopes to inspire all community-based organizations to create age-friendly partnerships with hospitals, health plans and with one another through regional networks.”

Rapid Response Improves Lives and Communities:

In many communities, there are people who call 911 frequently because they lack access to health care and social services. Instead, they use emergency medical services weekly or more frequently. Frequently, these are vulnerable, older adults with complex health and social needs, who are also low-income.

Rapid Response addresses the needs of these high-utilization people. Rapid Response connects clients with much-needed health and social supports and provides ongoing case management, reducing the use of 911 and hospital emergency rooms for these needs.

In Alameda County, California, the Rapid Response partnership includes Alameda County Emergency Medical Services (EMS), area hospitals, fire departments, Adult Protective Services, community-based organizations, and DayBreak. This strategic partnership of 20 organizations launched in 2018, with the goal of reducing the high utilization of EMS by older adults for non-emergency issues.

DayBreak facilitated the design process for Rapid Response. DayBreak invited local partners to an ongoing series of workshops to design the solution together.

Key to the program’s success in Alameda County is fast referrals. DayBreak professionals meet clients at the hospital shortly after the client calls 911 and EMS is contacted.

At the hospital, DayBreak assesses the person’s unmet needs. DayBreak then draws on the local network to bring in the needed services and supports. This allows the client to leave the hospital and safely go home, where they can live independently and healthier – with the right supports in place. DayBreak continues to follow-up with each client to ensure their wellbeing.

Replicating Rapid Response:

“Our goals are to help more elders in the East Bay, and to support other communities in designing Rapid Response for their specific needs. We view our role as that of facilitator, not program owner. We guide disparate teams to find common ground and co-create solutions. These solutions improve health, energize teams and lift-up communities,” said Ofra Paz.

Beginning with only a small amount of seed money in 2018, DayBreak secured additional grant funding and hired a team of full-time staff to support the program.

About DayBreak

DayBreak Adult Care Centers (“DayBreak”) improves the lives of vulnerable older adults and their family caregivers. In addition to the Rapid Response Case Management program, key programs include:

  • Co-op adult day community pilot program, where caregivers can donate volunteer hours in exchange for respite care;
  • Caring-for-the-Caregiver education series;
  • Senior injury- and fall-prevention programs;
  • Phone counseling and assistance for seniors and caregivers.

Learn more at

About The John A. Hartford Foundation

The John A. Hartford Foundation, based in New York City, is a private, nonpartisan, national philanthropy dedicated to improving the care of older adults. The leader in the field of aging and health, the Foundation has three priority areas: creating age-friendly health systems, supporting family caregivers and improving serious illness and end-of-life care. For more information, visit and follow @johnahartford.

About n4a

The National Association of Area Agencies on Aging (n4a) is a 501(c)(3) membership association representing America’s national network of 622 Area Agencies on Aging (AAAs) and providing a voice in the nation’s capital for the more than 260 Title VI Native American aging programs. n4a’s primary mission is to build the capacity of our members so they can help older adults and people with disabilities live with dignity and choices in their homes and communities for as long as possible. For more information, visit and follow @n4aACTION.

About the Aging and Disability Business Institute

The mission of n4a’s Aging and Disability Business Institute is to build and strengthen partnerships between aging and disability community-based organizations and the health care system. The Business Institute receives funding from The John A. Hartford Foundation, The SCAN Foundation and the Administration for Community Living and is led by n4a.

Abridge and Mila partner to apply advances in AI to medical conversations

News Image

The healthcare AI startup that helps patients better stay on top of their health, Abridge, announced a partnership with the University of Montreal AI research institute Mila. The collaboration will deepen research contributions to the rapidly evolving field of medical conversation understanding and expand Abridge’s machine learning capabilities.

“Our mission at Abridge is to help people understand and follow-through on their health — much of which is powered by machine learning,” said Sandeep Konam, CTO and co-founder of Abridge. “From our earliest days, our goal has been to advance medical conversation AI and improve healthcare delivery experiences for people and their doctors. Our partnership with Mila gives us the opportunity to expand our research and continue to engage with leading innovators. The progress we make together will benefit many more people than either of us might reach on our own.”

Abridge highlights the key details of medical conversations, including instructions, medications, and follow-ups, making it easier to revisit important details and share the conversation with family. Abridge also shares clinically structured summaries with health professionals to help them save time and focus on patient experiences and outcomes. To solve complex challenges in understanding and summarizing medical conversations, the company invested upfront in annotating a one-of-a-kind, de-identified dataset containing over 10,000 hours of transcribed conversations from fully informed and consenting patients. Using this rich dataset, they built domain adaptation modules that can correct transcription errors, classifiers that can flag key takeaways, and language generation models that can create actionable summaries. Abridge contributes regularly to premier machine learning conferences and workshops, in the spirit of promoting open research and collaborating closely with academic communities.

Mila’s dedication to the socially responsible and beneficial development of AI closely aligns with Abridge’s commitment to ensuring that their technology is distributed fairly to all groups and will lead to more medical comprehension for everyone. “Since our founding, we’ve been committed to solving problems according to people’s real needs and pursuing the development of AI for social good,” said Yoshua Bengio of Mila. “That’s why we’re looking forward to partnering with Abridge — not only for our shared focus on machine learning, but also because we are both dedicated to developing technology responsibly and in service of others.”


Abridge helps people stay on top of their health. Whether an appointment takes place in-person or at home via telemedicine, Abridge records the conversation and creates an interactive transcript highlighting the key medical points. By keeping patients, their families, and clinicians on the same page, Abridge brings more understanding and follow-through to every conversation. Visit and @AbridgeHQ to get the latest information.


Founded by Professor Yoshua Bengio of the Université de Montréal, Mila is a research institute in artificial intelligence which rallies about 700 researchers specializing in the field of deep learning. Based in Montreal, Mila’s mission is to be a global pole for scientific advances that inspires innovation and the development of AI for the benefit of all. Mila is a non-profit organization recognized globally for its significant contributions to the field of deep learning, particularly in the areas of language modelling, machine translation, object recognition and generative models.

Share article on social media or email:

Boston IVF and Reproductive Care Center Announce New Partnership

Reproductive Care Center

Both Boston IVF and Reproductive Care Center have a shared vision to deliver the highest quality of integrated, holistic care and help our patients become parents in the shortest time possible.

Boston IVF, a pioneer in reproductive healthcare and innovative research, announced it has entered into a partnership with Reproductive Care Center, a leading provider of fertility and family-building services in Utah and Idaho.

As individuals and couples continue to seek reproductive care across the country at historically high levels during the COVID-19 pandemic, the new partnership enables Reproductive Care Center (RCC) to further enhance its standing as a clinical leader in the region. Boston IVF’s vast library of data analysis and clinical protocols lead to less time in treatment, less total cost, and an improved chance for success. Additionally, RCC and future patients will benefit from Boston IVF’s robust scientific team and international research program, which regularly conducts pioneering clinical trials that contribute to industry-wide improvements in all aspects of care – including egg and embryo development.

With the acquisition of RCC, Boston IVF continues to expand its national fertility network, which now includes over 30 reproductive endocrinologists across 30 centers nationwide. In March, Boston IVF acquired Ohio Reproductive Medicine, Central Ohio’s largest IVF program.

“We are pleased to welcome such a respected leader in reproductive medicine to the Boston IVF fertility network,” said David Stern, MBA – Chief Executive Officer of Boston IVF. “Both Reproductive Care Center and Boston IVF have a shared vision to deliver the highest quality of integrated, holistic care and help our patients become parents in the shortest time possible. RCC’s long history of scientific innovation and clinical success aligns perfectly with our business model, philosophy, and mission.”

As part of the new partnership, Reproductive Care Center – which operates four centers across Utah and Idaho – also welcomes incoming reproductive endocrinologist Kristi Maas, MD to its Salt Lake City-based team. Dr. Maas joins RCC from a leading Southern California fertility practice, where she played a significant role in assisting individuals and couples with their family-building needs. Additionally, her arrival at RCC/Boston IVF serves as a long-awaited reunion; Dr. Maas is a graduate of the prestigious Beth Israel Deaconess Medical Center/Harvard Medical School/Boston IVF Reproductive Endocrinology and Infertility (REI) Fellowship program, which trains the country’s top-tier fertility specialists.    

“It is very important for us to join forces with a leader that shares our vision of the future,” said James Heiner, MD – Reproductive Care Center founder and chief reproductive endocrinologist. “The RCC/Boston IVF partnership offers us the unique opportunity to implement substantial clinical, scientific, and operational enhancements that differentiate us from other centers and positively impact the lives of our patients. To add Boston IVF’s resources, experience, and reproductive lab science – which directly influences success rates – to an already highly-effective model of care is a significant and compelling opportunity for those in our local community who wish to build a family.”

“Boston IVF admires Reproductive Care Center’s desire to expand,” said Haryanto Hokianto, Vice President of Business Development at Boston IVF. “We applaud Dr. Keith Blauer and fellow RCC team members for their progressive vision of reproductive care and dedication to creating unique financing programs that help to make treatment affordable. As a strategic partner, it is important for our local physicians to operate autonomously and work collaboratively to grow the practice and enhance an already-superior level of RCC patient care in Utah and Idaho.”


Boston IVF is one of the largest and most experienced fertility networks in the United States, with more than 100,000 babies born since 1986. Founded as one of the nation’s first private practice IVF centers, the Boston IVF network has grown to include over 30 reproductive endocrinologists across 30 centers throughout Massachusetts, Maine, New Hampshire, New York, Idaho, Indiana, Ohio, Rhode Island, and Utah. A renowned innovator of reproductive technologies, advanced protocols, and cutting-edge research, Boston IVF has achieved numerous “firsts” in the field of reproductive care. Its scientific and research arm continues to pave the way for breakthroughs in fertility care and its accredited REI Fellowship Program has graduated numerous reproductive endocrinologists as part of its mission to train the next generation of fertility experts. In 2019, this leading provider of fertility services in the United States was acquired by Eugin, one of the largest IVF networks in the world, with centers throughout Europe and South America. For more information, please visit


Reproductive Care Center, the first private practice fertility clinic in Utah, has helped individuals and couples to build their families for over 25 years. Utilizing the most innovative and medical protocols, RCC offers a full array of services including IUI, IVF, egg freezing, donor egg IVF, genetic testing, male infertility, LGBTQIA+ family-building and more. Utilizing a myriad of proven reproductive technologies, RCC is able to identify unique trends that often lead to a swifter, more accurate diagnosis for the rarest of infertility cases. For more information, please visit

Share article on social media or email:

Healthy Directions and Whitaker Nutrition launch new one-a-day vegetarian Vision Essentials ULTRA supplement for comprehensive eye support

“People of all ages are starting to really feel the effects of excessive screen time and are looking for a simple solution to not only shield their eye health but also improve their quality of life. Vision Essentials ULTRA can provide that relief.”

Healthy Directions is pleased to announce the introduction of Vision Essentials ULTRA, a breakthrough one-a-day vision supplement in its highly popular and efficacious Whitaker Nutrition line. Dr. Julian Whitaker has been widely recognized as a pioneer and leader in nutritional medicine for over 30 years, particularly in the field of eye health and vision support.

“The original Vision Essentials supplement debuted over 20 years ago, and since then our R&D team has constantly tracked clinical research and customer feedback in order to make ongoing improvements,” says Ben Teicher, President of Healthy Directions. “Vision Essentials ULTRA represents the culmination of that work, and I’m so proud to finally be able to offer it to the thousands–if not millions–of people dealing with eye strain, fatigue, and stress over the implications of ever-increasing levels of blue light exposure.”

Vision Essentials ULTRA contains a full 40 milligrams of clinically validated Lutemax® 2020, an advanced blend of the carotenoids lutein, zeaxanthin, and meso-zeaxanthin that mimics the exact ratio of these compounds found in nature. Lutein and other carotenoids serve as a macular shield for your eyes against blue light and supercharging your macular pigment optical density or MPOD (often referred to as “internal sunglasses”).

Taking vision health well beyond macular support, Vision Essentials ULTRA is the first vision formula to combine lutein with research-backed extracts Bilberon® Bilberry and Saffr’Inside™ Saffron. In a recent study, adults using digital devices for more than four hours per day saw significant improvements in eye fatigue, dryness, redness and itching, neck and shoulder stiffness, and eye moisture after taking Bilberon®. Safr’Inside™ saffron complements these benefits by promoting a better mood, regulating stress levels, and reducing occasional anxiousness. Participants in a recent study of saffron intake for over a year also anecdotally reported improved vision in low light, better contrast and color perception, better reading ability, and enhanced visual acuity.

“My team and I are incredibly impressed with the clinical results of Lutemax®, Bilberon® and Safr’Inside™ and worked closely with the scientists behind these extracts to create a comprehensive, easy-to-take formula that can benefit everyone,” said Dr. Irfan Qureshi, Vice President of Research & Development for Healthy Directions. “People of all ages are starting to really feel the effects of excessive screen time and are looking for a simple solution to not only shield their eye health but also improve their quality of life,” he added. “Thanks to the effective, highly-researched ingredients, Vision Essentials ULTRA can provide that relief in just one pill a day–and fill a critical void in the vision health marketplace.”

Vision Essentials ULTRA also includes vitamins A and C, plus zinc and copper. These nutrients are critical for vision and macular health and were a key part of the original AREDS research that was groundbreaking for raising awareness about the importance of supplementation for eye health.    

Already generating significant sales and positive feedback from consumers, Vision Essentials ULTRA is available at, through the Healthy Directions catalog, and on Amazon.

About Healthy Directions: Healthy Directions LLC, a subsidiary of Adaptive Health LLC, is a leading health publisher and direct-to-consumer retailer of doctor-formulated nutritional supplements and skincare products dedicated to providing people with a better path to better health. Healthy Directions provides expert guidance and advanced nutritional supplements from some of America’s most knowledgeable and highly respected integrative- and alternative-health doctors including Julian Whitaker, MD; Dr. David Williams; Stephen Sinatra, MD; Drew Sinatra, ND; Briana Sinatra, ND; Joseph Pergolizzi, Jr., MD; and Kulreet Chaudhary, MD. For more information, please visit

About Adaptive Health: Adaptive Health is a leader in science-based product development with a full portfolio of scientifically formulated nutritional health brands, including Nugenix®, Instaflex®, Peptiva®, Lumiday®, Dr. Sinatra®, Williams Nutrition®, Whitaker Nutrition®, LifeBiome®, and Trilane®. Adaptive Health products are sold in many major retailers across North America and internationally, as well as via its innovative direct-to-consumer ecommerce platform. For more information, please visit

Share article on social media or email:

Healthcare Facilities Maximize Operating Room Utilization with Picis 10 MR1


Picis 10 MR1 builds upon the Picis culture of listening to customers and developing solutions that are important to solve current challenges.” – Nikhil Bhatia, Director of Product Strategy

Picis Clinical Solutions, Inc. (Picis) announces the launch of the first Minor Release of Picis 10 (MR1). The release focuses on enhancements to the scheduling area of Picis 10, including displaying utilization metrics for a selected OR and surgeon block time. This allows for the ability to quickly create or edit surgeon block times and utilize machine learning to predict case times. These metrics help to optimize Operating Room efficiency by minimizing any idle times or identifying overtime scenarios.

Additionally, Picis has included the ability to document implants and surgical supplies used on a case via barcode scanning. All modern 3D barcode formats are supported for documentation on case records with this release.

Picis 10 MR1 builds upon the Picis culture of listening to customers and developing solutions that are important to solve current challenges. As we recover from the pandemic, maximizing the usage of the OR to handle the patient backlog in a safe manner becomes more important than ever. The new updates to Picis 10, in conjunction with PriorityQ, provide our customers with a compelling toolkit to manage their surgical backlog and schedules quickly and efficiently.” – Nikhil Bhatia, Director of Product Strategy, Picis.

Many other exciting enhancements that Picis customers have requested for on the Picis Ideas Portal have been added into Picis 10 MR1. To learn more, contact Nikhil Bhatia.


Picis Clinical Solutions, Inc. (Picis) is a global provider of clinical information solutions that automate the entire perioperative experience with one continuous patient record, from preop to anesthesia through PACU. Picis continues to focus and specialize the integrated suite of solutions in life-critical areas of the hospital where the patients are the most vulnerable, the care process is the most complex, and an increasing majority of hospital costs and potential revenue are concentrated. The software enables rapid, sustained delivery of clinical documentation, and financial and operational results. From department performance to patient case costing, hospitals benefit from the ability to interact with the data needed to help clinicians improve patient care, engagement, and hospital revenue goals. Picis Clinical Solutions, a wholly-owned subsidiary of N. Harris Computer Corporation, is headquartered in Wakefield, Massachusetts with licensed systems for use at more than 400 hospitals worldwide.

Share article on social media or email:

New Faith-Filled and Educational Book Provides Helpful Resources and Inspiration for Anyone Dealing with Cancer or Other Health Diagnoses

News Image

We were truly blessed with a miracle of healing and wanted others to have some of the same tools we took advantage of to make it through

When a person or loved one is diagnosed with a devastating diagnosis such as cancer, the journey ahead is often filled with fear and a sense of hopelessness. Author Mari. D. Martin and her husband Chris faced this difficult journey when he was diagnosed with throat cancer and are sharing their inspiring and candid account to encourage others they are not alone in “Come Home Alive: The Power of Knowing How to Work Together to Make it Through the Crisis of Cancer.”

Determined not to let the cancer diagnosis take control of their lives, Mari and Chris set forth on a six-part plan for him to come home alive. The couple utilized their 24 years of experience as Kolbe Certified consultants to practice what they taught others regarding self-awareness, strengths identification, communication needs, role alignment, and the environment each person needs to thrive. For Chris to thrive again, he needed to be in an environment that allowed him to heal and thrive; and as his loving caregiver, Mari provided that for him while still staying true to herself.

The author shares the steps that allowed her and Chris to get through their crisis, while still in love as ever before so that other couples and families experiencing similar health challenges can learn from their experience and come out stronger in the end. Through her book, Mari also sheds light on the benefits and importance for young people to get the HPV vaccine as many head, neck, and oral cavity cancers, including Chris’ throat cancer, are caused by the HPV virus.

“We were truly blessed with a miracle of healing and wanted others to have some of the same tools we took advantage of to make it through,” said Mari.

“This book follows the story of Chris’s cancer journey, but more than that, it shows the abounding and steadfast love of true soul mates as they go through the battle with the disease. It is uplifting, candid, and filled with the power of the Blessed Trinity in the lives of those who adore Him, lean on Him, and are uplifted in the dark alley ways they are forced to traverse,” a 5-star reviewer wrote about the book.

Ultimately, the book will inspire many to have hope and persevere through the fearful journey of a devastating health diagnosis while also helping readers see how turning to God gave Mari and Chris the strength they needed to keep fighting and encourage readers to do the same.

“Come Home Alive: The Power of Knowing How to Work Together to Make it Through the Crisis of Cancer”

By Mari D. Martin

ISBN: 978-1-6642-2299-1 (sc); 978-1-6642-2300-4 (hc); 978-1-6642-2298-4 (e)

Available through Amazon, Barnes & Noble and WestBow Press

About the author

Mari D. Martin is president of Performance Strategies Group, Inc. (PSG), a consulting and coaching organization. She is the first recipient of the Kolbe Professional Award and of the Mari Martin award, given to a community member for their help to reduce domestic and sexual violence. Martin is a child of God, wife, mother, grandmother, sister, and daughter. She is an avid reader, runner, golf enthusiast, and football fan. Martin and her husband Chris currently reside in Holland, Michigan, and “Come Home Alive” is her first book. To learn more, please visit

Review Copies & Interview Requests:                    

LAVIDGE Publicity                    

Lauren Dickerson


Share article on social media or email:

Successfully Used on Animals Escaping from Fire, Noted Veterinary Surgeon Dr. Theresa Fossum Adds Wound Therabee, with Manuka Honey For Animal Cuts and Burns, To Her Line

Wound Therabee

We were so impressed by the Manuka Honey/Cannabinoid ointment that is now available as Wound Therabee. Finding this incredible product was one of the few positives to come out of our fire experience.

Noted veterinary surgeon Dr. Theresa Fossum DVM, MS, Ph.D., Diplomate ACVS, and author of the most referenced book on pet operations, Small Animal Surgery, has added a new product to her popular line of natural animal supplements Dr. Fossum’s Pet Care, Wound Therabee, with certified Manuka Honey for animal cuts and burns.

While in development, the product was used during Northern California’s Bear Fire in 2020 on numerous dogs and cats that had been burned escaping from the flames by veterinarians from the VCA Valley Oak Veterinary Center in Chico, California. The co-medical director there, Dr. Daniel Gebhart noted, “we were so impressed by the Manuka Honey/Cannabinoid ointment that is now available as Wound Therabee. Finding this incredible product was one of the few positives to come out of our fire experience. With over 80 fires already this year, and with more to come since it’s only July, we urge our veterinary colleagues to stock up on this incalculably valuable salve.” (see before/after picture attached)

Wound Therabee combines sterile Manuka honey with hemp extract. This formulation is a great all-around first aid kit addition for wounds, sores, cuts, and burns. It contains 100% active Leptospermum honey (Manuka honey), harvested by bees in New Zealand and infused with potent cannabinoids including CBD, CBG, and CBN.

While honey is often used as a folk remedy, regular table honey is actually not sterile and not antibacterial. Wound Therabee features an active ingredient that is unique to Manuka honey produced by bees pollinating the Leptospermum Scopartum shrub. It’s produced and regulated in New Zealand, is traceable, is free of pesticides, chemical residues, and antibiotics, and has a unique manuka factor (UMF) of 12.

Manuka honey is quite an impressive substance! Indigenous cultures have used this honey as a wound treatment for thousands of years due to its natural broadband healing properties from a highly concentrated viscous solution of floral sugars and amino acids derived from the crop of the bee. And it can be stored and remain stable unrefrigerated for over a thousand years!

The properties of Manuka honey include low water content, acidity (pH 3.9), high sugar content (80%), high osmolarity, it generates hydrogen peroxide, antimicrobial peptide (Bee defensin-1), phytochemicals including flavonoids, terpenes, antioxidants and polyphenols, and methylglyoxal (MGO) that correlates with Unique Manuka Factor (UMF).

The addition of cannabinoids to the Manuka honey may help reduce discomfort and itching.

Dr. Fossum notes, “While our proof of concept came from a very intense situation, we are proud to offer this natural ointment to our fellow veterinarians and pet parents for hopefully less dire but useful animal wound care.”

Share article on social media or email: